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SUMMARY 20 
In mammals, specification of the three major germ layers occurs during gastrulation, when cells 21 
ingressing through the primitive streak differentiate into the precursor cells of major organ 22 
systems. However, the molecular mechanisms underlying this process remain unclear, as 23 
numbers of gastrulating cells are very limited. In the E6.5 mouse embryo, cells located at the 24 
junction between the extra-embryonic region and the epiblast on the posterior side of the embryo 25 
undergo an epithelial-to-mesenchymal transition (EMT) and ingress through the primitive streak 26 
(PS). Subsequently, cells migrate, either surrounding the prospective ectoderm contributing to the 27 
embryo proper, or into the extra-embryonic region to form the yolk sac (YS), umbilical cord and 28 
placenta. Fate mapping has shown that mature tissues such as blood and heart originate from 29 
specific regions of the pre-gastrula epiblast1 but the plasticity of cells within the embryo and the 30 
function of key cell type-specific transcription factors remain unclear. Here we analyse 1,205 cells 31 
from the epiblast and nascent Flk1+ mesoderm of gastrulating mouse embryos using single cell 32 
RNA-sequencing, representing the first transcriptome-wide in vivo view of early mesoderm 33 
formation during mammalian gastrulation. Additionally, using knock-out mice, we study the 34 
function of Tal1, a key hematopoietic transcription factor (TF), and demonstrate, contrary to 35 
previous studies performed using retrospective assays2,3, that Tal1 knock out does not 36 
immediately bias precursor cells towards a cardiac fate.  37 
 38 
MAIN TEXT 39 
 40 
Traditional experimental approaches for genome-scale analysis rely on large numbers of input 41 
cells and therefore cannot be applied to study early lineage diversification directly in the embryo. 42 
To address this, we used single cell transcriptomics to investigate mesodermal lineage 43 
diversification towards the haematopoietic system in 1,205 single cells covering a timecourse 44 
from early gastrulation at embryonic day E6.5 to the generation of primitive red blood cells at 45 
E7.75 (Figure 1a, Extended Data Fig. 1a,2a). Using previously published metrics (Methods), we 46 
observed that the data were of high quality. 501 single cell transcriptomes were obtained from 47 
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dissected distal halves of E6.5 embryos sorted for viability only, which contain all of the epiblast 48 
cells, including the developing PS, and a limited number of visceral endoderm and extra-49 
embryonic ectoderm cells. From E7.0, embryos were staged according to anatomical features 50 
(Methods) as primitive streak (S), neural plate (NP) and head fold (HF).  The VEGF receptor Flk1 51 
(Kdr) was used to capture cells as it marks much of the developing mesoderm4. During 52 
subsequent blood development, Flk1 is down-regulated and CD41 (Itga2b) is up-regulated5. We 53 
therefore also sampled cells expressing both markers and CD41 alone at the NP and HF stages 54 
(Figure 1a; Extended Data Fig. 1b, 2a), giving a total of 138 cells from E7.0 (S), 259 from E7.5 55 
(NP) and 307 from E7.75 (HF).  56 
 57 
Following rigorous quality control, 2,085 genes were identified as having significantly more 58 
heterogeneous expression across the 1,205 cells than expected by chance (Extended Data Fig. 59 
2b-d). Unsupervised hierarchical clustering in conjunction with a dynamic hybrid cut (Methods) 60 
yielded 10 robust clusters with varying contributions from the different embryonic stages (Figure 61 
1b, Extended Data Fig. 3, Methods, cell numbers in Extended Data Fig. 3h). Using t-Stochastic 62 
Neighbor Embedding (t-SNE) dimensionality reduction to visualise the data, three major groups 63 
were observed, one comprising almost all E6.5 cells, another mainly consisting of earlier S and 64 
NP stage cells, and a third containing predominantly later HF stage cells (Figure 1c). Importantly, 65 
clusters were coherent with the t-SNE visualization except for the small cluster 5 (Figure 1d).  66 
 67 
The expression of key marker genes allowed us to assign identities to each cluster: visceral 68 
endoderm, extra-embryonic ectoderm, epiblast, early mesodermal progenitors, posterior 69 
mesoderm, endothelium, blood progenitors, primitive erythrocytes, allantoic mesoderm, 70 
pharyngeal mesoderm (Figure 1b, Extended Data Fig. 4 and Extended Data Fig. 3h). Because of 71 
the limited cell numbers and lack of markers for their prospective isolation, conventional bulk 72 
transcriptome analysis of these key populations has never before been attempted.  73 
 74 
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Since the T-box transcription factor Brachyury - encoded by the T gene – marks the nascent PS6, 75 
we investigated the gene expression programs associated with T induction in the E6.5 cells 76 
(cluster 3). T expression was restricted to a distinct subset of epiblast cells found closest to 77 
cluster 4 (Figure 1d, Extended Data Fig. 5b), with rare isolated cells within the bulk of the epiblast 78 
population also expressing moderate levels, consistent with priming events for single 79 
gastrulation-associated genes. T expression correlated with other gastrulation-associated genes 80 
including Mixl1 and Mesp1 (Figure 2a), with Mesp1 highly expressed only in the small subset of 81 
cells situated at the pole of the E6.5 epiblast cluster (association of T and Mesp1 expression: p-82 
value 3x10-15, Fisher’s exact test). We also observed a subset of cells distinct from the T+/Mesp1+ 83 
population, which expressed Foxa2, suggestive of endodermal priming7 (Extended Data Fig. 5d). 84 
 85 
We next identified genes displaying correlated expression with T, which identified known markers 86 
and regulators such as Mixl1, and also genes not previously implicated in mammalian 87 
gastrulation, such as Slc35d3, an orphan member of a nucleotide sugar transporter family8 and 88 
the retrotransposon-derived transcript Cxx1c9 (Figure 2b and Supplementary Information Table 89 
1).  Genes negatively correlated with T were consistently expressed across the majority of 90 
epiblast cells, suggesting that cells outside the PS have not yet committed to a particular fate, 91 
consistent with the known plasticity of epiblast cells in transplant experiments10. Ingressing 92 
epiblast cells undergo an EMT, turning from pseudo-stratified epithelial cells into individual motile 93 
cells, a conformational change associated with alterations in cell size and shape11.  Our E6.5 94 
epiblast cells were isolated using index sorting thus providing a forward scatter (FSC) value for 95 
each cell. As shown in Figure 2c, T+/Mesp1+ co-expressing cells showed a significant reduction in 96 
FSC values compared to T+/Mesp1- and T- cells. Since FSC correlates positively with cell size, 97 
this observation provides a direct link between specific transcriptional programs and 98 
characteristic physical changes associated with gastrulation. As T+/Mesp1+ cells also express 99 
Mesp2, this observation was consistent with the known EMT defect in Mesp1/Mesp2 double 100 
knock-out embryos12. Index sorting therefore linked expression changes with dynamic physical 101 
changes similar to those recognised to occur during chicken gastrulation13.  102 
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 103 
We next focused on mesodermal lineage divergence during and immediately after gastrulation. 104 
We reasoned that approaches analogous to those used to order single cells in developmental 105 
pseudotime could be used to infer the location of cells in pseudospace, specifically with respect 106 
to the anterior-posterior axis of the primitive streak (Figure 3a). To this end, we used diffusion 107 
maps14, a dimensionality reduction technique particularly suitable for reconstructing 108 
developmental trajectories15. We identified the diffusion-space direction that most likely 109 
represents true biological effects (see Methods), which we interpreted as the pseudospace 110 
coordinate (red line in Figure 3b, Extended Data Fig. 6a-d). Hierarchical clustering revealed three 111 
groups of genes (Figure 3c, Extended Data Fig. 6e, Supplementary Information Table 4) showing 112 
a gradient of expression along the pseudospace axis. These were assigned as anterior (darker 113 
blue, 334 genes) and posterior (lighter blue, 87 genes) due to the enrichment of genes with 114 
known differential expression along the anterior-posterior axis of the PS (Figure 3d, Extended 115 
Data Fig. 6f-h, 7). A third cluster was expressed highly at either end of the pseudospace axis 116 
(turquoise, 41 genes). Interestingly, the more posterior Flk1+ mesodermal cells are associated 117 
with the allantois, blood and endothelial clusters (Figure 1d, Extended Data Fig. 5c), which are 118 
known to arise from the posterior primitive streak. Gene ontology analysis revealed that the 119 
putative anterior genes were associated with terms relating to somite development, endoderm 120 
development and Notch signaling, consistent with a more anterior mesoderm identity16 121 
(Supplementary Information Table 2a; Extended Data Fig. 6h). Conversely, the putative posterior 122 
mesoderm cluster was associated with BMP signaling, hindlimb development and endothelial cell 123 
differentiation, which consistent with the posterior portion of the streak17.  124 
 125 
Although derived from the same embryonic stages as the mesodermal progenitor cells, cluster 7 126 
lacks expression of genes such as Mesp1, yet expresses Tal1, Sox7, Tek (Tie2) and Fli1 which 127 
are vital for extra-embryonic mesoderm formation (Figure 1b, Extended Data Fig. 5, 7). 128 
Expression of Kdr and Itga2b (Extended Data Fig. 5b) further highlights clusters 7 and 8 (brown) 129 
as corresponding to the developmental journey towards blood (Figure 4a), with a transition to 130 
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mostly HF stage cells in cluster 8 and increasing expression of embryonic haemoglobin Hbb-bh1 131 
(Figure 4b). Given the apparent trajectory of blood development from cluster 7 to 8, we used an 132 
analogous approach to that described above to recover a pseudotemporal ordering of cells 133 
(Figure 4a, Extended Data Fig. 8a-d and Methods). 803 genes were down-regulated, including 134 
the haematovascular TF Sox7 which is known to be down-regulated during blood commitment15 135 
(Figure 4c,d, Extended Data Fig. 8e,f). 67 genes were up-regulated including the erythroid-136 
specific TFs Gata1 and Nfe2, and embryonic globin Hbb-bh1 (Figure 4b, d, e, Extended Data Fig. 137 
8). 27 genes were transiently expressed, including the known erythroid regulator Gfi1b. 138 
Significant GO terms associated with the up-regulated genes were indicative of erythroid 139 
development, while down-regulated genes were associated with other mesodermal processes 140 
including vasculogenesis and osteoblast differentiation (Supplementary Information Table 2b).  141 
 142 
Gata1 null embryos die at around E10.5 due to the arrest of yolk sac erythropoiesis18. We 143 
generated genome-wide ChIP-seq data for Gata1 in haematopoietic cells derived following 5 144 
days of ESC in vitro differentiation (Extended Data Fig. 9a-c). The group of up-regulated genes 145 
from the pseudotime analysis showed a pronounced overlap with Gata1 targets (p < 2.2x10-16, 146 
Fisher’s test) including known targets such as Nfe2 and Zfpm1 (Figure 4f,g, Extended Data Fig. 147 
9d,e, Supplementary Information Table 6). Integration of single cell transcriptomics with 148 
complementary TF binding data therefore predicts likely in vivo targets of developmental 149 
regulators such as Gata1.  150 
 151 
Two contrasting mechanisms are commonly invoked to explain how drivers of cell fate 152 
determination regulate cell type diversification. The first involves fate restriction through a step-153 
wise sequence of binary fate choices and is supported by mechanistic investigations using 154 
embryonic stem cell (ESC) differentiation2,19. The alternative invokes acquisition of diverse fates 155 
from independent precursor cells and is commonly supported by cell transplantation and lineage 156 
tracing analysis (Figure 5a)1,10,20,21. In contrast to the retrospective nature of transplantation and 157 
lineage tracing experiments where measurements are typically obtained a day or more after cell 158 
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fate decisions are made, single cell transcriptomics allows cellular states to be determined at the 159 
moment when fate decisions are executed since low cell numbers are not a limiting factor.  160 
 161 
The bHLH TF Tal1 (also known as Scl) is essential for the development of all blood cells22,23 with 162 
strong expression in posterior mesodermal derivatives (Figure 5b). Tal1-/- bipotential 163 
blood/endothelial progenitors cannot progress to a haemogenic endothelial state19, Tal1 164 
overexpression drives transdifferentiation of fibroblasts into blood progenitors24 and Tal1-/- 165 
mesodermal progenitors from the yolk sac give rise to aberrant cardiomyocyte progenitors when 166 
cultured in vitro2.  However, the precise nature of the molecular defect within Tal1-/- mesodermal 167 
progenitors within the embryo has remained obscure, because cell numbers are too small for 168 
conventional analysis.   169 
 170 
We profiled single Flk1+ cells from 4 wild type and 4 Tal1-/- embryos obtained from E7.5 (NP) to 171 
E8.25 (4 somite stage) (256 wild type and 121 Tal1-/- cells; Figure 5c, Extended Data Fig. 10), 172 
and computationally assigned cells to the previously defined 10 clusters (Methods). Cells from 173 
wild type embryos contributed to all clusters, while Tal1-/- embryos did not contain any cells 174 
corresponding to the blood progenitor and primitive erythroid clusters (yellow and brown, Figure 175 
5d) consistent with the known failure of primitive erythropoiesis in Tal1-/- embryos23 and their lack 176 
of CD41 expression (Figure 5c).  177 
 178 
Fifty-one Tal1-/- cells were mapped to the endothelial (red) cluster, which therefore allowed us to 179 
investigate the early consequences of Tal1 deletion in this key population for definitive 180 
haematopoietic development (Figure 5d, Supplementary Information Table 7, 8). Fifty genes were 181 
down-regulated in Tal1-/- endothelial cells (fold change < 0.67, 5% FDR). These include known 182 
regulators of early blood development (Itga2b, Lyl1, Cbfa2t3, Hhex, Fli1, Ets2, Egfl7, Sox7, 183 
Hoxb5), consistent with Tal1 specifying a haematopoietic fate in embryonic endothelial progenitor 184 
cells19, and in particular Hoxb5, which has recently emerged as a powerful marker for definitive 185 
blood stem cells25. Single cell profiling also identified genes with altered distributions of 186 
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expression. For example, Sox7 changed from a largely unimodal pattern in wild-type cells to a 187 
bimodal on/off pattern in Tal1-/- endothelial cells, while Cbfa2t3 showed the opposite pattern 188 
(Figure 5d).   189 
 190 
However, we did not observe up-regulation of cardiac markers in Tal1-/- endothelial cells (Figure 191 
5e, Supplementary Information Table 8, 9). Previously, this up-regulation had been observed in 192 
YS endothelial cells collected 1-1.5 days later than our data2, and had been taken as evidence 193 
that Tal1 acts as a gatekeeper controlling the balance between alternative cardiac and 194 
blood/endothelial fates within single multipotent mesodermal progenitors3. Our results however 195 
suggest that the primary role of Tal1 is induction of a blood program, and the subsequent ectopic 196 
expression of cardiac genes may be the result of secondary induction events acting on a still 197 
relatively plastic mesodermal cell blocked from executing its natural developmental program.   198 
 199 
Here we have used single cell transcriptomics to obtain a comprehensive view of the 200 
transcriptional programs associated with mammalian gastrulation and early mesodermal lineage 201 
diversification. Further technological advances to resolve epigenetic processes at single cell 202 
resolution26 and match single cell expression profiles with spatial resolution27,28 are likely key 203 
drivers of future progress in this field. Finally, our analysis of Tal1-/- embryos illustrates how the 204 
phenotypes of key regulators can be re-evaluated at single cell resolution to advance our 205 
understanding of early mammalian development.  206 
 207 
Accession Numbers: 208 
ChIP-seq data are available at the NCBI Gene Expression Omnibus portal, accession number 209 
GSE74994. Processed data are also available at http://codex.stemcells.cam.ac.uk. RNAseq data 210 
are available at Array Express accession E-MTAB-4079 and E-MTAB-4026. Processed RNAseq 211 
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Figure Legends: 309 
Figure 1: Single cell transcriptomics identifies 10 populations relevant to early 310 
mesodermal development. a) Whole mount images and schematics of E6.5 to E7.75 embryo 311 
sections. Colors indicate approximate locations of sorted cells. Anterior, left; posterior, right. 312 
Scale bars: 200µm. b) Heatmap showing key genes distinguishing 10 clusters. Colored bars 313 
indicate assigned cluster (top), stage (middle: turquoise, E6.5; purple, primitive streak (S, E7.0); 314 
green, neural plate (NP, E7.5); red, headfold (HF, E7.75)) and the sorted population (bottom: 315 
green, E6.5 epiblast; blue, Flk1+; turquoise, Flk1+CD41+; red, Flk1-CD41+). c) t-SNE of all 1205 316 
cells colored by embryonic stage, and d) according to clusters in (b). 317 
 318 
Figure 2: Transcriptional program associated with T induction in E6.5 epiblast cells. a) t-319 
SNE of the 481 E6.5 cells in cluster 3.  Points are colored by expression of T (Brachyury) and 320 
Mixl1, Mesp1 and Frzb. b) Heatmap showing the 10 genes most highly positively and negatively 321 
correlated with T (Supplementary Information Table 1). c) Forward scatter (FSC) for the 481 E6.5 322 
epiblast cells in cluster 3, with cells grouped according to T/Mesp1 expression. Boxplots indicate 323 
the median and interquartile range.  P-values were calculated using a two-sided Welch’s t-test for 324 
samples with unequal variance, with FDR correction for multiple testing. 325 
 326 
Figure 3: Dimensionality reduction reveals transcriptional profiles associated with cell 327 
location in the embryo. a) Schematic of tissue emergence along the anterior-posterior primitive 328 
streak, derived from 29. Mesodermally- and endodermally-derived tissues are marked by a red 329 
and green line, respectively. b) Diffusion map of cells in cluster 4 with pseudospace axis in red. 330 
Projections onto this axis represent pseudospace coordinates. c) Heatmap for differentially 331 
expressed genes along the pseudospace axis, showing genes more highly expressed in the 332 
anterior (dark blue) and posterior region (light blue), or highly expressed at either end 333 
(aquamarine). d) Expression profiles for example genes.  334 
 335 
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Figure 4: Inferring the transcriptional program underlying primitive erythropoiesis. a) 336 
Diffusion map of clusters 7 and 8 displaying the inferred pseudotime axis (blue). b) Expression of 337 
Hbb-bh1 ordered by pseudotime (local polynomial fit). c) Heatmap ordered along the pseudo-time 338 
axis. Horizontal bars indicate cluster and developmental stage. Genes shown were repressed 339 
(grey), activated (green) or transiently expressed (blue).  d) Examples of activated and repressed 340 
genes and e) Gata1 as in (b). f) UCSC Browser tracks for Gata1 ChIP-seq and input in 341 
Runx1+Gata1+ cells; the Nfe2 locus is shown. g) Percentage of genes in each group identified in 342 
C overlapping Gata1 targets.  343 
 344 
Figure 5: Analysis of Tal1-/- embryos suggests independent fate acquisition. a) Schematic 345 
of two cell fate diversification models. b) Tal1 in situ hybridization at HF stage. Scale bar: 200µm.  346 
c) Flow cytometry of WT and Tal1-/- mice at HF and E8.25. d) Blood program genes are 347 
differentially expressed between nascent mesoderm (blue) and endothelial (red) and blood cells 348 
(brown). Differential expression between Tal1-/- and WT endothelial cells (lower left t-SNE) 349 
identified 50 down-regulated genes. Gene set overlap (central panel) indicates failure to induce 350 
the blood program in Tal1-/- endothelium (p < 2.2 x 10-16, Fisher's test). On the right are 351 
expression distributions for selected genes in wild type (black) or Tal1-/- (grey) endothelial cells. 352 
e) For genes previously reported3 to be bound and activated (left panel) or bound and repressed 353 
(right panel) by Tal1, fold change between Tal1-/- and WT endothelium (defined in D) is plotted 354 
against average expression. Red circles: genes with a fold change > 1.5 and an FDR < 0.05. 355 
356 
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Methods 357 
Timed matings and embryo collection  358 
All procedures were performed in strict adherence to United Kingdom Home Office regulations. 359 
Timed matings were set up between CD1 mice (which produce large litters). Embryos were 360 
staged according to the morphologic criteria of Downs and Davies30, and classified broadly as 361 
primitive streak (S), neural plate (NP) or head fold (HF) stage. Suspensions of cells from 362 
individual embryos were prepared by incubating with TrypLE Express dissociation reagent (Life 363 
Technologies) at 37°C for 10 minutes and quenching with heat inactivated serum. All cells were 364 
stained with DAPI for viability.  At E6.5, the distal half of the embryo was dissected and 365 
dissociated into a single cell suspension, and live cells were sorted.  For E7.0 and older, 366 
suspensions consisted of the whole embryo and were also stained with Flk1-APC (AVAS12 at 367 
1:400 dilution; BD Bioscience) and only Flk1+ cells were collected. For cell sorting of CD41+Flk1- 368 
and CD41+Flk1+ cells from NP stage and HF stages, suspensions were stained with Flk1-APC, 369 
PDGFRa-PE (APA5 at 1:200 dilution; Biolegend) and CD41-PEcy7 (MWReg30 at 1:400 dilution; 370 
Biolegend) for 20 minutes at 4°C as described31. Cells were sorted from 7 E6.5 embryos.  Flk1+ 371 
cells were sorted from 3 S stage, 4 NP stage and 3 HF stage embryos (Extended Data Fig. 1a). 372 
CD41+Flk1- and CD41+Flk1+ cells were sorted from the same embryos, an additional 8 each at 373 
NP and HF stages (Extended Data Fig. 1b). Cell sorting was performed with a BD Influx cell 374 
sorter in single cell sort mode with index sorting to confirm the presence of a single event in each 375 
well. Additional cells were sorted into tissue culture plates to visually confirm the presence of 376 
single events. 377 
 378 
To obtain Tal1-/- cells, timed matings were set up between Tal1LacZ/+ mice32. Flk1+ cells were 379 
sorted as above from 4 embryos for each genotype: from 1 embryo for each genotype at NP and 380 
4 somite (4S) stages, from 2 HF stage embryos for Tal1LacZ/LacZ (designated Tal1-/-), 1 HF stage 381 
WT embryo and 1 WT embryo intermediate between NP and HF stages. Genotyping PCR using 382 
1/20 suspension cells was performed as described previously32. 383 
 384 
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Single-cell RNA sequencing  385 
Library preparation and mapping of reads 386 
scRNA-seq analysis was performed using the Smart-seq2 protocol as previously described33. 387 
Single cells were sorted by FACS into individual wells of a 96-well plate containing lysis buffer 388 
(0.2 % (v/v) Triton X-100 and 2 U/μl RNase inhibitor (Clontech)) and stored at -80°C. Libraries 389 
were prepared using the Illumina Nextera XT DNA preparation kit and pooled libraries of 96 cells 390 
were sequenced on the Illumina Hi-Seq 2500. Reads were mapped simultaneously to the M. 391 
musculus genome (Ensembl version 38.77) and the ERCC sequences using GSNAP (version 392 
2014-10-07) with default parameters. HTseq-count34 was used to count the number of reads 393 
mapped to each gene (default options).  394 
 395 
Identification of poor quality cells 396 
To assess data quality35, five metrics were used: (i) total number of mapped reads, (ii) fraction of 397 
total reads mapped to endogenous genes, (iii) fraction of reads mapped to endogenous genes 398 
that are allocated to mitochondrial genes, (iv) fraction of total reads mapped to ERCC spike-ins 399 
and (v) level of sequence duplication (as estimated by FastQC, version 0.11.4,  400 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc). 401 
 402 
For all downstream analyses, we only retained samples that had (i) more than 200,000 reads 403 
mapped (either to ERCC spike-ins or endogenous mRNA), (ii) more than 20% of total reads 404 
mapped to mRNA, (iii) less than 20% of mapped reads allocated to mitochondrial genes, (iv) less 405 
than 20% of reads mapped to ERCC spike-ins and (v) less than 80% of duplicated sequences. 406 
Out of the 2,208 cells that were captured across the two experiments, 1,582 (i.e., ~72% of the 407 
total) passed our quality check. A t-SNE projection36 of the values of these five metrics (Extended 408 
Data Fig. 2b) shows that most of discarded cells tend to cluster together and fail at least two 409 
criteria. All metrics were standardised before applying t-SNE with the “RtSNE” function (default 410 
parameters) from the R package “RtSNE” (version 0.1) 37. 411 
 412 
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Normalization of read counts  413 
The data was normalised for sequencing depth using size factors38 calculated on endogenous 414 
genes. By doing so, we also normalise for the amount of RNA obtained from each cell39, which is 415 
itself highly correlated with cell cycle stage40. 416 
 417 
Highly variable genes and GO enrichment analysis 418 
Highly variable genes were identified by using the method described in Brennecke et al.39. In 419 
brief, we fitted the squared coefficient of variation as function of the mean normalised counts39. In 420 
the fitting procedure, in order to minimise the skewing effect due to the lowly expressed genes39, 421 
only genes with a mean normalised count greater than 10 were used. Genes with an adjusted p-422 
value (Benjamini-Hochberg method) less than 0.1 were considered significant (red circles in 423 
Extended Data Fig. 2c). This set of highly variable genes was used for the clustering analysis 424 
discussed below. The GO enrichment analysis was carried out using TopGO in its “elimination 425 
mode” with Fisher’s exact test; we considered as significant GO categories with an unadjusted p-426 
value below 10-4 . 427 
 428 
Differentially expressed genes 429 
In order to find genes differentially expressed between two groups of cells we used edgeR41  430 
(version 3.12). Before running edgeR, we excluded genes annotated as pseudogenes in 431 
Ensembl, sex-related genes (Xist and genes on the Y chromosome) and genes that were not 432 
detected or were expressed at very low levels (we considered only genes that had more than 10 433 
reads per million in a number of cells greater than 10% of the cells in the smaller group being 434 
compared). The function “glmTreat” was then used to identify the genes having a fold change 435 
significantly greater than 1.5 at a FDR threshold equal to 0.05. 436 
 437 
Clustering analysis 438 
Clustering analysis was performed on the 1,205 WT cells from the first experiment that passed 439 
the QC. The Spearman correlation coefficient, ρ, was computed between the transcriptome of 440 
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each pair of cells, which was then used to build a dissimilarity matrix defined as (1-ρ)/2. 441 
Hierarchical clustering was carried out (“hclust” R function with the “average” method) on the 442 
dissimilarity matrix and clusters were identified by means of the Dynamic Hybrid Cut algorithm42. 443 
The R function “cutreeDynamic” with the “hybrid” method and a minimum cluster size equal to 10 444 
cells was used (“dynamicTreeCut” package, version 1.62). This function allows the user to 445 
specify the “deepSplit” parameter that controls the sensitivity of the method: higher values of this 446 
parameter correspond to higher sensitivity and can result in more clusters being identified, but 447 
also entail an increased risk of overfitting the data. The optimal trade-off between robustness of 448 
clustering and sensitivity was found by analyzing the results of the algorithm with all possible 449 
values of the deepSplit parameter (i.e. integer values from 0 to 4) on 100 subsamples of our data. 450 
In particular, in each subsample, we removed 10% of genes randomly selected before computing 451 
the dissimilarity matrix and applying the clustering algorithm.  452 
 453 
The statistics of the Pearson gamma and the average silhouette width (computed with the 454 
“cluster.stats” function included in the R package “fpc”, version 2.1-10)43,44 of the subsamples 455 
(see Extended Data Fig. 3a,b) suggest that with “deepSplit=2” a good compromise is reached 456 
between robustness and sensitivity for our data. We identified 10 different clusters as well as two 457 
outlier cells that, although similar in gene expression to the mesodermal progenitor cells (cluster 458 
4), were not assigned to any cluster by the algorithm, probably due to their relatively poor quality.  459 
 460 
We then evaluated how specifically each gene is expressed in any given cluster. First, we found 461 
the differentially expressed genes (as described above) between all pairs of clusters. Marker 462 
genes for cluster i are expected to be significantly up-regulated in i across all pairwise 463 
comparisons involving cluster i. The average rank of a marker gene across the pairwise 464 
comparisons provides a measure of how specifically the marker is expressed in the cluster. 465 
Extended Data Fig. 3c-f show the expression values of marker genes for four different clusters. 466 
We provide the full list of markers in Supplementary Information Table 3. The clusters were 467 
visualised by using t-SNE (as implemented in the “RtSNE” R package) on the dissimilarity matrix.   468 
19 
 
 469 
Single-cell trajectories in pseudo-space: the anterior/posterior axis of the primitive streak 470 
As discussed in the main text, cells allocated to cluster 4 (Figure 1b-d) are cells that have likely 471 
exited the primitive streak only recently. We sought to align the cells along a pseudospatial 472 
trajectory representing the anterior-posterior axis of the primitive streak, which would allow us to 473 
identify the likely original locations of each cell along such an axis. 474 
 475 
To do this we adopted an unsupervised approach: we did not use any prior information about 476 
marker genes, but selected the strongest signal present in this cluster of cells (controlling for 477 
potential batch effects) and later verified its biological meaning. We first used a diffusion map-478 
based technique to reduce the dimensionality of the dataset. Diffusion maps have recently been 479 
successfully applied to identify developmental trajectories in single-cell qPCR and RNA-seq 480 
data14,15. We used the implementation of the “destiny” R package (“DiffusionMap” function) 481 
developed by Angerer et al.45. We restricted the analysis to genes that are highly variable among 482 
cells in the blue cluster and have an average expression above 10 normalised read counts. The 483 
centered cosine similarity was used (“cosine” option in the “DiffusionMap” function) and only the 484 
first two diffusion components (DC1 and DC2) were retained for downstream analysis.  485 
 486 
In addition to biologically meaningful signals, batch effects (due to cells being sorted and 487 
processed on different plates) can also be present and induce structure within the data. While in 488 
our dataset the batch effect does not strongly influence the definition of different populations of 489 
cells, it might become relevant when finer structures within a single cluster of cells are considered 490 
(see Extended Data Fig. 6a). In order to tease apart the signals due to biological and batch 491 
effects, we computed the fraction of variance attributable to the batch effect along each direction 492 
in the diffusion space using a linear regression model. The direction “orthogonal” to the batch 493 
effect, i.e., the direction associated with the smallest fraction of variance explained by the batch 494 
effect, was considered as mostly driven by a biologically relevant signal. Hence, all cells were 495 
projected on this direction to obtain a “pseudo-coordinate” representing the state of a cell relative 496 
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to the biological process captured by the diffusion map. The direction was identified by the angle 497 
α that it formed with the DC1 axis (Extended Data Fig. 6c). 498 
 499 
Cells considered here are mostly from 2 batches including cells from the Primitive Streak stage 500 
(plate SLX-8408 and SLX-8409) and 2 batches including cells from the Neural Plate stage (plate 501 
SLX-8410 and SLX-8411; Extended Data Fig. 6b). For each of these two sets of batches, we 502 
computed the fraction of variance that can be explained by the batch covariate along any 503 
possible direction in the diffusion plot. The angles α1 and α2 corresponding to the directions 504 
orthogonal to the two batch effects are very close to each other (Extended Data Fig. 6c); we took 505 
the average		ߙഥ  between these two angles to approximate the direction orthogonal to both batch 506 
effects.  507 
 508 
Cells’ coordinates in the diffusion space were projected along the direction identified by		ߙഥ , and 509 
this projection was interpreted as a “pseudospace” coordinate representing the position of cells 510 
along the primitive streak (see main text and Figure 3). We tested the robustness of such a 511 
pseudospace coordinate by repeating the same analysis with alternative dimensionality reduction 512 
techniques (t-SNE and Independent Component Analysis), which gave highly correlated 513 
coordinates (see Extended Data Fig. 6d). A Principal Component Analysis carried out with a set 514 
of previously known markers for the anterior and posterior regions of the primitive streak also 515 
yielded a first component highly correlated with the pseudospace coordinate (see Extended Data 516 
Fig. 6d left panel). Moreover, the pseudospace coordinate had a positive (negative) correlation 517 
with the posterior (anterior) markers used (see Extended Data Fig. 6d right panel). These results 518 
strongly support the robustness of the signal we identified as well as its biological interpretation.  519 
 520 
Once the pseudospace trajectory was defined, we selected genes that were differentially 521 
expressed along the trajectory. First, we removed all genes that were not detected in any cell. 522 
Then, for each gene, we fitted the log10-expression levels (adding a pseudocount of 1) by using 523 
two local polynomial models: one with degree 0 and another with degree 2 (“locfit” function in 524 
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“locfit” R package, nearest neighbor component parameter equal to 1). The first, simpler model is 525 
better suited for genes that do not change their expression level along the trajectory. The second 526 
model has a greater number of parameters and is able to reproduce the more complex dynamics 527 
of genes that are differentially expressed.  528 
 529 
We evaluated these two models by using the Akaike information criterion (AIC), a score that 530 
measures how well the data are reproduced by the model and includes a penalization for more 531 
complex models46. Better models according to this criterion correspond to smaller AIC scores. 532 
To compute the AIC scores for the two models, we used the “aic” function available in the “locfit” 533 
R package, and then calculated the difference:  534 
∆AIC = AIC(degree = 2) – AIC(degree = 0) 535 
Negative values indicate that the more complex model with degree 2 local polynomials perform 536 
better, and therefore correspond to genes that are more likely to be differentially expressed. 537 
Genes having a ∆AIC < -2 were considered to be significantly differentially expressed along the 538 
trajectory46.  539 
 540 
A hierarchical tree was built with the normalised expression patterns of the 462 differentially 541 
expressed genes (function “hclust” with average linkage method and dissimilarity based on 542 
Spearman correlation) and a dynamic hybrid cut algorithm (“cutreeDynamic” function, minimum 543 
cluster size equal to 5) split this set of genes in 3 clusters according to the type of dynamics they 544 
have (see Figure 3, Extended Data Fig. 6e and Supplementary Information Table 4). 545 
 546 
Single-cell trajectories in pseudo-time: the blood developmental trajectory 547 
As discussed in the main text, clusters 7 and 8 (yellow and brown clusters in Figure 1b and 1d) 548 
include blood progenitors at different stages of differentiation. By using a procedure analogous to 549 
the one described above, we aligned these cells along a trajectory representing embryonic blood 550 
development. 551 
 552 
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Extended Data Fig. 8a shows the diffusion plot with cells from the yellow and the brown clusters. 553 
Most of these cells come from plates SLX-8344 and SLX-8345 that were collected from embryos 554 
at Neural Plate and late Head Fold stages (see Extended Data Fig. 8b). With a linear regression 555 
model, where we controlled for biological parameters like stage and sorting, we found the 556 
direction that correlates the least with the batch effect associated to these two plates and 557 
projected all cells onto it (Extended Data Fig. 8c). Note that the minimum correlation with the 558 
batch effect is achieved at a very small value of α (~10°, see Extended Data Fig. 8c), suggesting 559 
that the first diffusion component is mainly driven by a biologically meaningful signal and the 560 
batch effect plays a minor role here even at this more detailed scale of analysis. The new cell 561 
coordinate obtained from the projection was interpreted as a “pseudotime” coordinate, which 562 
represents the differentiation stage of each cell along their journey towards erythroid fate. As 563 
expected, cells in the yellow cluster have a smaller pseudotime coordinate compared to the 564 
brown cluster that is mainly composed of more differentiated primitive erythroid cells. An analysis 565 
with alternative dimensionality reduction techniques yielded highly correlated pseudotime 566 
coordinates, suggesting the robustness of the signal (Extended Data Fig. 8d). Furthermore, our 567 
biological interpretation of the pseudotime coordinate is supported by the expression pattern of 568 
genes that are known to be up-regulated or down-regulated along the blood developmental 569 
trajectory, as is clear via Principal Component Analysis (see Extended Data Fig. 8f). 570 
 571 
By using the filtering and clustering procedure described in the previous section, we were able to 572 
detect 897 genes that were differentially expressed along the trajectory, which were divided in 3 573 
clusters, each displaying a different type of dynamics (see Extended Data Fig. 8e and 574 
Supplementary Information Table 5). 575 
 576 
Random Forest to allocate cells to previously identified clusters 577 
Cells captured in the Tal1 experiment (testing dataset) were allocated to the clusters we 578 
previously identified by using a Random Forest algorithm47 (R package “randomForest”, version 579 
4.6-12)48 trained on the cells captured in the first experiment (training dataset). The rank-580 
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normalised expression levels of all highly variable genes in the training dataset were used as 581 
variables (the R function “rank” was used for normalization, ties were averaged). The random 582 
forest algorithm was first used on the training data to assess variable importance with 1,000 583 
classification trees. The 25% most important variables were selected to grow another set of 1,000 584 
trees that were then used for the classification of the testing dataset. With this filtered set of 585 
variables the out-of-bag error estimate was ~4.8%.  586 
 587 
The quality of allocation of each cell in the testing dataset was verified by computing the median 588 
of pairwise dissimilarities (defined as (1-ρ)/2, with ρ being the Spearman correlation) of that cell to 589 
all other cells in the training data allocated to the same cluster. Cells in the testing dataset having 590 
a median pairwise dissimilarity larger than the maximum of the medians of pairwise dissimilarities 591 
of cells in the training data were considered to be “unclassified” (~1.8% of all cells from the 592 
testing dataset). For the identification of differentially expressed genes between clusters in the 593 
testing data, only cells that were confidently allocated to the clusters (i.e., cells with a minimum 594 
difference of 10% probability between the best and the second best cluster allocation) were used. 595 
 596 
Generation, maintenance and haematopoietic differentiation of Runx1-GFP/Gata1-mCherry 597 
ESCs  598 
Runx1GFP/+:Gata1mCherry/Y ESCs were generated from morulae as described previously49,50. ESCs 599 
were grown on gelatinised plates (0.1 % gelatin in water) at 37°C and 5 % CO2 in ESC media 600 
(Knockout DMEM (Life Technologies) with 15 % FCS (batch-tested for ESC culture; Life 601 
Technologies), 2mM L-glutamine (PAA Laboratories), 0.5 % P/S, 0.1mM β-mercaptoethanol (Life 602 
Technologies) and 103 U/ml recombinant LIF (ORF Genetics)). Cells were passaged with TrypLE 603 
Express dissociation reagent (Life Technologies) every 1-3 days. ESCs were differentiated as 604 
EBs as previously described31,51. EBs were harvested into Falcon tubes after 5 days of culture 605 
and dissociated with TrypLE Express dissociation reagent and prepared for FACS. 606 
 607 
ChIP-seq 608 
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ChIP was performed as described52 with modifications for low cell numbers53. Approximately 609 
7x106 FACS-sorted day 5 EB cells (Runx1-ires-GFP+/Gata1-mCherry+; Extended Data Fig. 9a) 610 
per ChIP were cross-linked using formaldehyde to a final concentration of 1%. As samples were 611 
pooled from several sorts, isolated nuclei were frozen on dry ice-cold isopropanol and stored at -612 
80°C.  During the immunoprecipitation step, 4 μl recombinant histone 2B (New England Biolabs) 613 
and 1 μl of mouse RNA (Qiagen; diluted 1/5 in IP dilution buffer) were added as carriers, followed 614 
by 7 μg of primary antibody (rabbit anti-Gata1, Abcam ab11963). Sequencing libraries were 615 
prepared using the TruSeq Kit (Illumina) for high throughput sequencing on an Illumina HiSeq 616 
2500, according to manufacturer’s instructions, with size selection for fragments of 150-400 bp. 617 
 618 
ChIP-seq mapping and analysis 619 
Alignment of the ChIP-seq reads to the mouse mm10 genome, quality control and peak calling 620 
were performed according to the data pipeline set out by Sanchez-Castillo et al54. Peak calling 621 
was performed using MACS255 with p=1e-6. Post-processing using in-house scripts converted the 622 
peak coordinates to 400 bp based on peak summits given in the MACS output. Coordinates of 623 
genomic regions that lie at the end of chromosomes and/or in repeat regions were discarded from 624 
the final high-confidence peak lists. PolyAPeak56 was run in R to remove abnormally shaped 625 
peaks. Peaks were assigned to genes using an in-house script according to whether they 626 
overlapped with a known TSS or fell within 50 kb each side of a gene. 627 
 628 
In situ hybridization 629 
Whole-mount in situ hybridization for Tal1 was performed as described previously57. In situ 630 
hybridization probe for Tal1 was synthesised using published sequence (Tal1 860-1428, 631 
accession number M59764) with the DIG RNA labeling kit (Roche). 632 
 633 
Code availability 634 
All data were analysed with standard programs and packages, as detailed above.  Code is 635 
available on request.636 
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Extended Data Figure Legends: 637 
Extended Data Figure 1: Fluorescence activated cell sorting of single cells. a) Flk1+ cells 638 
were sorted from 3 embryos at S and HF stages and 4 embryos at NP stage. Labels such at ‘S4’ 639 
refer to the embryo number in the metadata available online at 640 
http://gastrulation.stemcells.cam.ac.uk/scialdone2016. b) CD41+Flk1- cells (red gate) and 641 
CD41+Flk1+ (green gate) cells were sorted from 8 embryos each at NP and HF stages. Each 642 
stage was sorted on two occasions.  Labels above FACS plots refer to the sort and embryo 643 
number in the metadata available online, as above. In all plots, pink text indicates the percentage 644 
of cells in that gate. 645 
 646 
Extended Data Figure 2:  Quality control of single cell RNA-seq data. a) Table showing 647 
numbers and estimates of numbers of cells of different phenotypes present in embryos between 648 
E6.5 and E7.75 (HF stage) and numbers sorted for this study.  (*) Total cell numbers for E6.5 are 649 
from Beddington and Robertson (1999)58  and (§) total numbers and numbers of Flk1+ cells are 650 
from Moignard et al., (2015)15.  Percentages of cells expressing Flk1 and/or CD41 at NP and HF 651 
stages are the average values from the embryos used in this study and were used to calculate 652 
the estimated numbers present in embryos from the total cell numbers. ND, not done.  b) t-SNE 653 
representation of the five metrics used to assess the quality of the samples. Only cells that 654 
passed all criteria (blue circles) were used for downstream analysis. c) Squared coefficient of 655 
variation (CV2) as a function of the mean normalised counts (µ) for genes across all cells. The 656 
green line shows the fit CV2 = a1/μ + α0. All highly variable genes (with an adjusted p-value < 0.1) 657 
are marked by red circles. d) Number of genes detected (i.e., with more than 10 normalised read 658 
counts) in cells across the different clusters in the WT (left panel) and the Tal1-/- (right panel) 659 
mice. 660 
 661 
Extended Data Figure 3: Identifying cell clusters. The Dynamic Hybrid Cut algorithm was 662 
used with all the possible values of the “deepSplit” parameter on 100 bootstrapped subsamples. 663 
To assess the quality of the clustering, the Pearson gamma (a) and the average silhouette width 664 
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(b) were calculated. Higher values of these parameters correspond to better clustering. The 665 
Pearson gamma represents the correlation between the dissimilarity of samples and a binary 666 
variable that equals 1 for pairs of samples in the same cluster and 0 for samples in different 667 
clusters. The average silhouette width measures the average separation between neighboring 668 
clusters43,44. At “deepSplit”=2 the Pearson gamma is highest whereas the average silhouette 669 
width begins to decrease. This suggests that at such a value of the “deepSplit” parameter a good 670 
compromise between robustness and sensitivity is achieved. The Pearson gamma and the 671 
average silhouette width were computed with the R function “cluster.stats” in the “fpc” package 672 
(version 2.1-9). (c-f) Examples of marker genes for four clusters:  Mesp1 for cluster 4 (top-ranked 673 
marker) (c), Sox18 for cluster 6 (second-ranked) (d), Hbb-bh1 for cluster 8 (fourth-ranked) (e) 674 
and Alx1 for cluster 10 (top-ranked) (f). The y-axis shows the log10 normalised expression of the 675 
genes. g) Dendrogram showing the clustering of the cells in the first experiment. The colors at the 676 
bottom indicate the cluster each cell was assigned to by the dynamic hybrid cut algorithm. Cluster 677 
assignment was used to sort cells in Figure 1b. h) Identities were assigned to the 10 clusters in 678 
Figure 1c based on the expression of key genes associated with various mesodermal lineages or 679 
spatial locations within the embryo. 680 
 681 
Extended Data Figure 4: Expression of key marker genes in E7.0-7.75 embryos. Schematic 682 
representations of expression patterns were generated from published in situ hybridization data 683 
(see citations) for key markers of clusters 1 (magenta, visceral endoderm59), 2 (pink, extra-684 
embryonic ectoderm61), 6 (red, YS endothelium62), 9 (black, allantois63,64) and 10 (green, second 685 
heart field65,66). Anterior is shown on the left and posterior on the right. Also shown is the t-SNE 686 
for all cells or cells from E7.0 onwards (S, NP and HF stages) indicating expression of each gene 687 
(white, low; purple, high). 688 
 689 
Extended Data Figure 5: Expression of key genes used for sorting single cells. a) t-SNE as 690 
in Figure 1 showing the sorting strategy for each of the 1,205 cells. b) Expression of Flk1 (Kdr), 691 
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CD41 (Itga2b), Scl (Tal1), Gata2 and T (Brachyury) superimposed onto the t-SNE. c) t-SNE 692 
showing only the cells from S, NP and HF stages, colored according to cluster as in Figure 1c 693 
and E. d) t-SNE for the 481 E6.5 cells in cluster 3, as in Figure 2a.  Each point is colored by 694 
expression of T and Foxa2. 695 
 696 
Extended Data Figure 6: Pseudospace analysis of cluster 4 correlates with anterior-697 
posterior position along the primitive streak. a) Diffusion plot of cells in cluster 4. Different 698 
colors correspond to different plates and different lanes of flow cells. b) Table showing the 699 
number of cells in each stage analysed on the different lanes of flow cells (S, Primitive streak; 700 
NP, Neural plate; HF, Head fold). c) A direction in the diffusion space can be identified by the 701 
angle α that it forms with the first diffusion component (left panel). For each value of α the right 702 
panel shows the percentage of variance explained by the batch effect associated to plates SLX-703 
8408 and SLX-8409 (orange line) and plates SLX-8410 and SLX-8411. α1 and α2 are the angles 704 
corresponding to directions that correlate the least with the batch effect (i.e., variance explained 705 
by the batch effect is minimum). d) The use of alternative dimensionality reduction techniques 706 
results in the identification of highly correlated pseudo-space coordinates. A t-SNE projection of 707 
the dissimilarity matrix was carried out (perplexity set to 50), and the direction corresponding to 708 
the pseudo-space coordinate was estimated by minimizing the correlation with the batch effect 709 
(left panel; Spearman correlation between the two pseudo-space coordinates 0.79, p-value < 710 
2.2x10-16). Independent Component Analysis was performed on the dissimilarity matrix with the 711 
“fastICA” R function, and 3 independent components (corresponding to the 2 batch effects and 712 
the biological effect) were estimated. The presumptive pseudo-space coordinate is the 713 
component having the smallest correlation with the batch effects (right panel; Spearman 714 
correlation coefficient is 0.97, p-value < 2.2x10-16). e) Plots showing the average expression of 715 
genes in clusters 1-3 of Figure 3c along the pseudospace axis.  Gene expression levels are 716 
normalised between 0 and 1.  Black lines indicate the normalised mean expression levels of 717 
genes in each cluster as obtained from the fitting procedure and red shaded area indicates 718 
standard deviation. f) Expression of T as function of the pseudospace coordinate. g) Gene 719 
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expression levels for example genes showing high-low-high expression pattern across the blue 720 
cluster.  In B and C, putative anterior cells are to the left and posterior to the right as in C. Each 721 
dot represents a cell and red lines indicate fits based on local polynomial functions (see 722 
Methods). h) We performed Principal Component Analysis (PCA) on the cells in cluster 4 by 723 
using markers of presomitic mesoderm as anterior mesoderm markers and genes expressed in 724 
haemato-vascular and allantoic mesoderm as posterior markers67–80, as well as Podxl which was 725 
shown to separate distinct Flk1+ mesodermal lineages81. The first component explained 36% of 726 
the total variance and was highly correlated with the pseudo-space coordinate (left panel; 727 
Spearman rank correlation 0.84, p-value < 2.2x10-16). All the anterior markers were negatively 728 
correlated with the pseudo-space coordinate, whereas all posterior markers had a positive 729 
correlation (right panel). 730 
 731 
Extended Data Figure 7: Expression of key genes along the anterior-posterior axis of the 732 
primitive streak in E7.0-7.75 embryos. Schematic representations of gene expression were 733 
generated from published in situ hybridization data (see citations) for key markers of clusters 4 734 
(blue, mesoderm) and 7 (yellow, posterior mesoderm/blood progenitors). Expression of T 735 
(Brachyury)82 and Flk1 (Kdr – from in house data) are shown to illustrate the extent of the 736 
primitive streak at E7.5. Lefty2 and Tbx659 are expressed in the putative anterior portion of cluster 737 
4 and in more anterior regions of the primitive streak in in situ analysis. Tbx383 and Bmp484 are 738 
expressed in the more posterior portion of cluster 4 and in the embryo are expressed in the more 739 
posterior region of the primitive streak around the amnion and into the extra-embryonic 740 
mesoderm. Tek and Fli1 (from in-house data) are expressed in cluster 7 and in the embryo are 741 
found exclusively in the extra-embryonic portion. Also shown is the t-SNE for the cells from E7.0 742 
onwards (S, NP and HF stages) indicating expression of each gene (white, low; purple, high). 743 
 744 
Extended Data Figure 8: Pseudotime analysis of primitive erythroid development. a) 745 
Diffusion plot of cells in cluster 7 and 8. Different colors correspond to different plates and lanes 746 
of flow cells. b) Table showing the number of cells in each stage collected on the different plates 747 
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(S, primitive streak; NP, Neural plate; HF, Head fold). c) Analogously to Extended Data Fig. 6, the 748 
angle α identifies a direction in the diffusion space (left panel). The percentage of variance 749 
explained by the batch effect associated to plates SLX-8344 and SLX-8345 is plotted as function 750 
of α in the right panel. d) The pseudo-time coordinate is robust to the use of different 751 
dimensionality reduction techniques, as shown in the left panel with t-SNE (Spearman correlation 752 
0.92, p-value < 2.2x10-16) and in the right panel with Independent Component Analysis 753 
(Spearman correlation 0.97, p-value < 2.2x10-16 ; same procedure described in Extended Data 754 
Fig. 6d). e) Plots showing the average expression of genes in clusters 1-3 of Figure 4c along the 755 
pseudotime axis.  Gene expression levels are normalised between 0 and 1. Black lines are the 756 
average expression levels of genes in each cluster as obtained from the fitting procedure, after 757 
normalization. Red shaded areas indicate standard deviation. f) Principal Component Analysis 758 
was carried out on the expression pattern of genes known from previous studies to be up-759 
regulated or down-regulated along the blood developmental trajectory15,85–90.  The first principal 760 
component (explaining 44% of total variance) showed a very strong correlation with the pseudo-761 
time coordinate (left panel; Spearman correlation coefficient 0.91, p-value < 2.2x10-16). All up-762 
regulated (down-regulated) genes positively (negatively) correlate with the pseudotime coordinate 763 
(right panel). 764 
 765 
Extended Data Figure 9: ChIP-seq for Gata1 in ESC-derived haematopoietic cells. a) Flow 766 
cytometry for Gata1-mCherry and Runx1-IRES-GFP knock-in reporter genes in embryoid body 767 
cells after 5 days of haematopoietic differentiation. Cells were sorted for the expression of both 768 
Runx1-IRES-GFP and Gata1-mCherry knock-in reporter genes to provide in vitro equivalents of 769 
the developing primitive erythrocytes assayed by RNA-seq. The gate used for sorting is shown in 770 
red.  b) Numbers of reads and peaks identified for Gata1 and an input sample after mapping and 771 
peak calling.  4,135 Gata1 peaks were identified.  c) Distribution of Gata1 peaks between 772 
promoter, intragenic and intergenic sequences. d) UCSC genome browser tracks for Gata1 and 773 
input sample at the Zfpm1 (Fog1) locus known to be a target of Gata1, indicating the quality of 774 
30 
 
the ChIP-seq data. e) Expression of Gata1 target Zfpm1 during the pseudotimecourse for 775 
erythroid development, as in Figure 4. 776 
 777 
Extended Data Figure 10: Collection of embryos from Tal1 LacZ/+ crosses. a) Genotyping 778 
PCR for embryos from Tal1 LacZ/+ crosses. Lower band is the wild type allele and upper band is 779 
the mutant allele carrying a neomycin knock in.  Presence of both bands indicates heterozygosity.  780 
Embryos from which sequencing data were obtained are indicated with a red star and the number 781 
given corresponds to embryo identity in the metadata available online with the sequencing data. 782 
b) t-SNE as in Figure 5d showing Tal1 data (triangles) and original wild type data (grey circles).  783 
Tal1 data are colored according to the embryo stage from which they were collected: green, NP; 784 
red, HF; orange, 4SP. c) As in Figure 5d, showing the complete list of genes. d) Gene Set 785 
Control Analysis91 (GSCA) was used to identify statistically significant overlaps between genes 786 
significantly down-regulated in Tal1-/- compared with WT cells in the endothelial cluster (see 787 
Figure 5) and Tal1 targets identified by ChIP-seq. GSCA identified an enrichment of our gene set 788 
with Tal1 ChIP-seq in ESC-derived haemangioblasts and haemogenic endothelium92, but not 789 
ESC-derived haematopoietic progenitors92 or a haematopoietic progenitor cell line52. 790 
 791 
792 
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